Mark Weir-Smith is an experienced executive leader currently serving as the Head of Manufacturing - Drug Product at BioCina. They have over 20 years of expertise in pharmaceutical quality, operations, and regulatory affairs, having held key positions such as General Manager at Western Diagnostic Pathology and Director of Quality Operations at Sanofi Genzyme. Mark has also contributed to the industry as a board member for ISPE Australia and as a Medical Assessor for the National Association of Testing Authorities. They hold a degree in Medical Science from Curtin University and have furthered their education in leadership and business optimization at prestigious institutions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices